RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
IST:RTALB.E

Watchlist Manager
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS Logo
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
IST:RTALB.E
Watchlist
Price: 3.75 TRY -1.83% Market Closed
Market Cap: ₺1.9B

Operating Margin

-34.9%
Current
Improving
by 4.5%
vs 3-y average of -39.4%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-34.9%
=
Operating Income
₺-64.9m
/
Revenue
₺185.9m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-34.9%
=
Operating Income
₺-64.9m
/
Revenue
₺185.9m

Peer Comparison

Country Company Market Cap Operating
Margin
TR
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
IST:RTALB.E
1.9B TRY
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
US
Abbvie Inc
NYSE:ABBV
393.1B USD
Loading...
US
Amgen Inc
NASDAQ:AMGN
185.9B USD
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
172.7B USD
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
120.7B USD
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
78.5B USD
Loading...
AU
CSL Ltd
ASX:CSL
86.9B AUD
Loading...
NL
argenx SE
XBRU:ARGX
43.4B EUR
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...

Market Distribution

Lower than 95% of companies in Turkey
Percentile
5th
Based on 567 companies
5th percentile
-34.9%
Low
-16 384.1% — 1%
Typical Range
1% — 15.5%
High
15.5% — 944%
Distribution Statistics
Turkey
Min -16 384.1%
30th Percentile 1%
Median 6.4%
70th Percentile 15.5%
Max 944%

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
Glance View

Market Cap
1.9B TRY
Industry
Biotechnology

RTA Laboratuvarlari Biyolojik Ürünler Ilaç ve Makine Sanayi Ticaret AS engages in the production, research, and development in vitro diagnostics. Its diagnostic products include: Clinical Microbiology, such as chromogenic media, culture media in petri dishes, tubes and bottles, rodac petri surcheck, and tuberculosis diagnosis products; ELISA Kits, such as HBsAg ELISA Kit; Molecular Diagnostics, such as nucleic acid isolation kits, real-time PCR instruments, real-time PCR kits and RTA VOLTRAN voral detection system, as well as other tests. Its Research includes: dehydrated culture media, such as dehydrated chromogenic culture media; nucleic acid isolation kits and real-time PCR.

RTALB.E Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-34.9%
=
Operating Income
₺-64.9m
/
Revenue
₺185.9m
What is RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS's current Operating Margin?

The current Operating Margin for RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS is -34.9%, which is above its 3-year median of -39.4%.

How has Operating Margin changed over time?

Over the last 3 years, RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS’s Operating Margin has decreased from 19.1% to -34.9%. During this period, it reached a low of -103.1% on Sep 30, 2023 and a high of 19.1% on May 30, 2022.

Back to Top